Activity content starts in:
Industry Webcast
Advancing COVID-19 Prevention: The Role of PEP With XOCOVA® (ensitrelvir) Clinical EssentialsIndustry Webcast Sponsored by Shionogi; Not for CME/CE Credit
The period immediately following COVID-19 exposure represents a critical opportunity for intervention. This program will examine the ongoing burden of COVID-19, review the science supporting early antiviral intervention following exposure, and highlight pivotal Phase 3 SCORPIO-PEP data evaluating XOCOVA (ensitrelvir) for PEP. Attendees will gain practical insights into patient identification, treatment considerations, and real-world implementation scenarios to help reduce the risk of symptomatic COVID-19 following exposure.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 8/19/2026
Expiration Date: 8/19/2026
Topics
Faculty
Faculty
Jeffrey D. Klausner, MD, MPH
Learn MoreSupporters and Partners
Industry Sponsor
Shionogi, Inc.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.